Article Details
Retrieved on: 2024-08-06 20:50:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advancements in biotech, focusing on monoclonal antibodies targeting CD38 in multiple myeloma treatment. It highlights key drugs like daratumumab and isatuximab and the potential for increasing CD38 expression to enhance therapy efficacy.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here